The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

被引:6
作者
El Hasbani, G. [1 ]
Nassar, J. E. [2 ]
Ali, A. M. Elsayed [2 ]
Uthman, I. [3 ]
Jawad, A. [4 ]
机构
[1] Hartford HealthCare St Vincents Med Ctr, Dept Med, Bridgeport, CT 06606 USA
[2] Amer Univ Beirut, Fac Med, Beirut, Lebanon
[3] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut, Lebanon
[4] Royal London Hosp, Dept Rheumatol, London, England
关键词
Cigarette smoking; autoimmunity; spondyloarthritis; rheumatoid arthritis; pathophysiology; treatment; TUMOR-NECROSIS-FACTOR; CITRULLINATED PEPTIDE ANTIBODY; CIGARETTE-SMOKING; EXTRAARTICULAR MANIFESTATIONS; PSORIATIC-ARTHRITIS; DISEASE-ACTIVITY; RISK-FACTORS; FACTOR-ALPHA; RADIOGRAPHIC PROGRESSION; ANKYLOSING-SPONDYLITIS;
D O I
10.4081/reumatismo.2024.1572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Nicotine has major side effects on human health through numerous mechanisms, one of which is the alteration of the immune system and its genetic components. Such alteration can be a predisposing factor for autoimmune diseases such as spondyloarthritis (SpA) and rheumatoid arthritis (RA). This review aims to shed light on the effects of nicotine smoking on the pathophysiology, clinical presentation, and management of SpA and RA. Methods. This review looked into the studies, excluding case reports and series, which were cited by PubMed/MEDLINE. Results. Patients with established autoimmune conditions may have a different underlying pathophysiology and disease course when exposed to nicotine through cigarette smoking. Through the involvement of several cytokines, endothelial dysfunction, and epigenetic mechanisms, the severity of SpA is more prominent in smokers. The global health status, pain, and fatigue are worse in SpA patients. The evidence on the effect of nicotine smoking on the treatment of SpA is still limited. Nicotine can contribute to RA via the disruption of cellular regulatory activity, inflammatory responses, morphological, physiological, biochemical, and enzymatic responses. As such, smokers with RA have higher disease activity and are more likely to be seropositive through the citrullination of peptides. In addition, these patients are at risk of achieving a suboptimal response to tumor necrosis factor inhibitors. Conclusions. Cigarette smoking can substantially affect the pathophysiology and clinical presentation of patients with SpA and RA. The impact of nicotine on the management of these diseases still needs to be further studied.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 50 条
[41]   Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review [J].
Mease, Philip J. ;
Bhutani, Mohit Kumar ;
Hass, Steven ;
Yi, Esther ;
Hur, Peter ;
Kim, Nina .
RHEUMATOLOGY AND THERAPY, 2022, 9 (02) :331-378
[42]   Incidence of Chronic Persistent Rheumatoid Arthritis and the Impact of Smoking: A Historical Twin Cohort Study [J].
Svendsen, Anders J. ;
Junker, Peter ;
Houen, Gunnar ;
Kyvik, Kirsten O. ;
Nielsen, Christian ;
Skytthe, Axel ;
Holst, Rene .
ARTHRITIS CARE & RESEARCH, 2017, 69 (05) :616-624
[43]   Prevalence and Impact of Antibodies Against TNF Alpha Inhibitors in Rheumatoid Arthritis and Spondyloarthritis: Systematic Review and Meta-Analysis with Subgroup Analysis [J].
Mahmoud, Ines ;
Bouden, Selma ;
Charfi, Rim ;
Abid, Yosr ;
Dziri, Chedly ;
Ben Sassi, Mouna ;
Rouached, Leila ;
Ben Tekaya, Aicha ;
Tekaya, Raoudha ;
Saidane, Olfa ;
Abdelmoula, Leila .
CURRENT DRUG SAFETY, 2025,
[44]   Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis [J].
Bergstrom, Ulf ;
Jacobsson, Lennart T. H. ;
Nilsson, Jan-Ake ;
Berglund, Goran ;
Turesson, Carl .
RHEUMATOLOGY, 2011, 50 (11) :2005-2013
[45]   Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis [J].
Kim, Seong Kyu ;
Choe, Jung Yoon .
ARCHIVES OF RHEUMATOLOGY, 2018, 33 (02) :143-149
[46]   Sleep disorders in rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis [J].
Polak, Dagna ;
Korkosz, Mariusz ;
Gula, Zofia .
RHEUMATOLOGY INTERNATIONAL, 2025, 45 (02)
[47]   Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis [J].
van de Sande, Marleen G. H. ;
van Vollenhoven, Ronald F. .
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (04) :340-346
[48]   TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same? [J].
Rubbert-Roth, Andrea ;
Atzeni, Fabiola ;
Masala, Ignazio Francesco ;
Caporali, Roberto ;
Montecucco, Carlomaurizio ;
Sarzi-Puttini, Piercarlo .
AUTOIMMUNITY REVIEWS, 2018, 17 (01) :24-28
[49]   Cardiovascular Risk Factors and Metabolic Syndrome in Rheumatoid Arthritis and Spondyloarthritis: Correlation With Uric Acid Levels [J].
Agadayi, Ezgi ;
Yurdakul, Fatma Gul ;
Agadayi, Sitki ;
Bodur, Hatice ;
Kahveci, Rabia ;
Ozkara, Adem .
ERCIYES MEDICAL JOURNAL, 2019, 41 (03) :300-306
[50]   Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis [J].
Poddubnyy, Denis ;
Rudwaleit, Martin .
EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) :655-673